Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol

Epilepsia

Volumn 58, Issue 8, 2017, Pages e96-e100

  Rosenberg, Evan C ^a   Louik, Jay ^a   Conway, Erin ^a   Devinsky, Orrin ^a   Friedman, Daniel ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cannabidiol; Epilepsy; Pediatric; Quality of life; Seizures

Indexed keywords

CANNABIDIOL; ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ANXIETY DISORDER; ARTICLE; BEHAVIOR; BEHAVIOR DISORDER; BENIGN CHILDHOOD EPILEPSY; CAREGIVER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; DEPRESSION; DROWSINESS; DRUG DOSE TITRATION; ENERGY EXPENDITURE; FATIGUE; FEMALE; HELPLESSNESS; HUMAN; MALE; MEMORY; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SOCIAL INTERACTION; SOMNOLENCE; EPILEPSY; INFANT; PRESCHOOL CHILD; PSYCHOLOGY; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTICONVULSANTS; CANNABIDIOL; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; QUALITY OF LIFE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 85020692531     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.13815     Document Type: Article

References (15)

1. Sabaz M, Lawson JA, Cairns DR, et al. Validation of the quality of life in childhood epilepsy questionnaire in American epilepsy patients. Epilepsy Behav 2003;4:680–691.
2. Connolly AM, Sabaz M, Lawson JA, et al. Quality of life in childhood epilepsy: validating the QOLCE. J Paediatr Child Health 2005;41:157–158.
3. Devinsky O, Vickrey BG, Cramer J, et al. Development of the quality of life in epilepsy inventory. Epilepsia 1995;36:1089–1104.
4. Cramer JA, ILAE Subcommission on Outcome Measurement in Epilepsy. Principles of health-related quality of life: assessment in clinical trials. Epilepsia 2002;43:1084–1095.
5. Aaronson NK. Quality of life: what is it? How should it be measured? Oncology (Williston Park) 1988;2:64, 69–76.
6. Press CA, Knupp KG, Chapman KE. Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. Epilepsy Behav 2015;45:49–52.
7. Sabaz M, Cairns DR, Lawson JA, et al. The health-related quality of life of children with refractory epilepsy: a comparison of those with and without intellectual disability. Epilepsia 2001;42:621–628.
8. Sabaz M, Cairns DR, Lawson JA, et al. Validation of a new quality of life measure for children with epilepsy. Epilepsia 2000;41:765–774.
9. Devinsky O, Marsh E, Friedman D, et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol 2016;15:270–278.
10. O'Connell BK, Gloss D, Devinsky O. Cannabinoids in treatment-resistant epilepsy: a review. Epilepsy Behav 2017;70(pt B):341–348.
11. Porter BE, Jacobson C. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy Behav 2013;29:574–577.
12. Sabaz M, Lawson JA, Cairns DR, et al. The impact of epilepsy surgery on quality of life in children. Neurology 2006;66:557–561.
13. Jacoby A, Baker GA, Steen N, et al. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. community study. Epilepsia 1996;37:148–161.
14. Blessing EM, Steenkamp MM, Manzanares J, et al. Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics 2015;12:825–836.
15. Speechley KN, Ferro MA, Camfield CS, et al. Quality of life in children with new-onset epilepsy: a 2-year prospective cohort study. Neurology 2012;79:1548–1555.